Abbott Laboratories (ABT) Stock Price, Quote & AI Analysis

Live ABT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Abbott Laboratories.

TradeVae provides AI-driven analysis and real-time market intelligence for Abbott Laboratories (ABT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

ABT
Abbott Laboratories
real-time
$0.00 +0.00 (+0.00%)
Open
0.000000
High
0.000000
Low
0.000000
Volume
0
VWAP
-
Market Cap
$190,058,703,807.10
52W Range
$105.27 - $141.23
P/E Ratio
-
EPS
-
Dividend Yield
219.58%
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Apr 14, 2026 Q1
Before Open
EPS Estimate: $1.1671
Revenue Estimate: $11,136,154,919.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Abbott Laboratories's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Abbott Laboratories Overview

Company information

Company Overview

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Company Details
Market Cap
$190.11B
Shares Outstanding
1,738,871,919
Weighted Shares Outstanding
1,738,871,947
CEO
Robert B. Ford
Address
100 ABBOTT PARK ROAD, ABBOTT PARK, IL, 60064-3500
Employees
114,000
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Abbott Laboratories Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...